Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
2610 Ergebnisse für "age" unter Roche Glycart AG
Neovascular Age Related Macular
... responsibility for access to or use of this website, nor for any content therein. Neovascular Age Related Macular ... Degeneration nAMD is an advanced form of age-related macular degeneration, a progressive retinal disease ... Neovascular Age Related Macular ... https://medically.roche.com/hu/en/ophtalmology/diseases/neovascular- age-related-macular.html ... Neovascular Age Related Macular ...
Neovascular Age Related Macular
... responsibility for access to or use of this website, nor for any content therein. Neovascular Age Related Macular ... Degeneration nAMD is an advanced form of age-related macular degeneration, a progressive retinal disease ... Neovascular Age Related Macular ... https://medically.roche.com/hu/en/ophthalmology/diseases/neovascular- age-related-macular.html ... Neovascular Age Related Macular ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
379 Ergebnisse für "age" unter University Hospital Zurich, Research and Education Office
Endocrine and Age-related Myopathies – Universitätsspital Zürich
... starting after 40 years of age. A better understanding of this process at the molecular level is needed to ... age-related and endocrine myopathies (12/18- 11/22) Olga Mayenfisch Foundation Molecular Metabolism ... Endocrine and Age-related Myopathies – Universitätsspital Zürich ... https://new.usz.ch/fachbereich/endokrinologie/forschung/endocrine-and- age-related-myopathies/ ... Endocrine and Age-related Myopathies – Universitätsspital Zürich ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
4217 Ergebnisse für "age" unter Somagenetix
Benchmarking comes of age
... Benchmarking comes of age Zurich Open Repository and Archive University of Zurich University ... Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2019 Benchmarking comes of age Robinson ... Benchmarking comes of age ... Benchmarking comes of age Zurich Open Repository and Archive University of Zurich University ... Benchmarking comes of age ...
UZH - UZH Journal - Understanding the Present Age
... Understanding the Present Age History of the Contemporary World / Zeitgeschichte A new, specialized ... UZH - UZH Journal - Understanding the Present Age ... UZH - UZH Journal - Understanding the Present Age Home Main navigation Search Jump to content ... UZH - UZH Journal - Understanding the Present Age ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
2243 Ergebnisse für "age" unter University of Zurich
UZH - UZH Magazin - Women’s Hearts Age Differently
... Advertising Women’s Hearts Age Differently Cardiologist Catherine Gebhard’s research focuses on why ... the same age. Gebhard then went on to prove in her own study that the female heart contracts more ... UZH - UZH Magazin - Women’s Hearts Age Differently ... UZH - UZH Magazin - Women’s Hearts Age Differently Home Main navigation Search Jump to content ... UZH - UZH Magazin - Women’s Hearts Age Differently ...
Decoding Canaanite Pottery Paintings from the Late Bronze Age and I...
... Choi, Gwanghyun D (2016). Decoding Canaanite Pottery Paintings from the Late Bronze Age and Iron ... Age I: Classification and Analysis of Decorative Motifs and Design Structures – Statistics ... Decoding Canaanite Pottery Paintings from the Late Bronze Age and Iron Age I: Classification and ... Decoding Canaanite Pottery Paintings from the Late Bronze Age and Iron Age I: Classification and ... Decoding Canaanite Pottery Paintings from the Late Bronze Age and Iron Age I: Classification and ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
1160 Ergebnisse für "age" unter ETH Entrepreneurship
Bell, Art History in the Age of Bellori – Xenotheka
... Bell, Art History in the Age of Bellori – Xenotheka ... https://xenotheka.delbeke.arch.ethz.ch/bell-art-history-in-the- age-of-bellori/ ... Bell, Art History in the Age of Bellori – Xenotheka ...
Comments on: Bell, Art History in the Age of Bellori
... Comments on: Bell, Art History in the Age of Bellori Comments on: Bell, Art History in the Age of ... Comments on: Bell, Art History in the Age of Bellori ... https://xenotheka.delbeke.arch.ethz.ch/bell-art-history-in-the- age-of-bellori/feed/ ... Comments on: Bell, Art History in the Age of Bellori ...
Neurimmune Therapeutics AG
8952 Schlieren, Wagistrasse 18
+41 44 755 46 46
info@neurimmune.com
Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases.
Neurimmune Therapeutics AG
Wagistrasse 18
8952 Schlieren
23 Ergebnisse für "age" unter Neurimmune Therapeutics AG
Neurimmune - Old Age – life worth living for everyone
... All News and Press Releases Old Age – life worth living for everyone In 2012, one in eight elderly ... Neurimmune - Old Age – life worth living for everyone ... http://www.neurimmune.com/stories/old- age-life-worth-living-for-everyone.html ... Neurimmune - Old Age – life worth living for everyone ...
Neurimmune - ATTR Cardiomyopathy
... transthyretin (ATTR)-cardiomyopathy is an age-associated disease of the heart characterized by intramyocardial ... predominantly in men ≥ 60 years of age and can be diagnosed using echocardiography, scintigraphy and biopsies ... Cardiomyopathy Amyloid transthyretin (ATTR)-cardiomyopathy is an age-associated disease of the heart ... . The disease manifests predominantly in men ≥ 60 years of age and can be diagnosed using ...
Blutspende SRK Zürich
https://www.blutspendezuerich.ch/
8952 Schlieren, Rütistrasse 19
+41 58 272 52 52
info@zhbsd.ch
The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).
Blutspende SRK Zürich
Rütistrasse 19
8952 Schlieren
83 Ergebnisse für "age" unter Blutspende SRK Zürich
Extension of upper age limit for blood donation_ISBT_2011
... Extension of upper age limit for blood donation_ISBT_2011 EXTENSION OF UPPER AGE LIMIT FOR BLOOD ... /Zürich Background: The upper age limit for blood donations is still controversial1. With regard to ... Extension of upper age limit for blood donation_ISBT_2011 ... Extension of upper age limit for blood donation_ISBT_2011 EXTENSION OF UPPER AGE LIMIT FOR BLOOD ... Extension of upper age limit for blood donation_ISBT_2011 ...
Microsoft PowerPoint - HEV SGM 2013 [Kompatibilitätsmodus]
... seroprevalence for Anti-HEV-IgG of 8.9%. Increasing age of donors correlated with a significant higher HEV ... seroprevalence (see Figure 1). This holds true for the single age group 31-40 y Conclusion As a first conclusion ... seroprevalence for Anti-HEV-IgG of 8.9%. Increasing age of donors correlated with a significant higher HEV ... seroprevalence (see Figure 1). This holds true for the single age group 31-40 y Conclusion As a first conclusion ...
Molecular Partners AG
http://www.molecularpartners.com
8952 Schlieren, Wagistrasse 14
+41 44 755 77 00
Molecular Partners AG is a clinical-stage biopharmaceutical company, located in Schlieren, Switzerland, that is developing a new class of therapies known as DARPin® therapies.
Molecular Partners AG
Wagistrasse 14
8952 Schlieren
36 Ergebnisse für "age" unter Molecular Partners AG
Late-Stage Data from Abicipar in Age-Related Macular Degeneration t...
... News Release Details News Release Details Late-Stage Data from Abicipar in Age-Related Macular ... I (Friday, October 11, 4:18 – 4:58 PM; local Pacific Time): Abicipar for Neovascular Age‐related ... Late-Stage Data from Abicipar in Age-Related Macular Degeneration to be Showcased at American ... - age-related-macular-degeneration-be ... Late-Stage Data from Abicipar in Age-Related Macular Degeneration to be Showcased at American ...
CSL Vifor
https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor
8952 Schlieren, Zürcherstrasse 39D
+41 58 851 80 00
Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.
CSL Vifor
Zürcherstrasse 39D
8952 Schlieren
36 Ergebnisse für "age" unter CSL Vifor
Iron Deficiency Patient Stories | CSL
... deficiency since the age of 16. Sam's Story Sam was diagnosed with Crohn’s Disease and iron deficiency at 16 ... deficiency since the age of 16. Read Andy's Story Elena's Story Elena's symptoms came on gradually. Read ...
CSL Annual Report 2022 – Page 37
... season. FLUCELVAX® QUADRIVALENT was also approved for expanded age indications down to six months of age ... in the US. FLUCELVAX® QUAD was also approved for expanded age indications down to six months of age ... Hemisphere 2022 influenza season. FLUCELVAX® QUADRIVALENT was also approved for expanded age indications down ... to six months of age in the US. FLUCELVAX® QUAD was also approved for expanded age indications down ...
Bio-Technopark Schlieren-Zürich
8952 Schlieren, Wagistrasse 23
+41 76 336 99 44
mario.jenni@bio-technopark.ch
The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.
Bio-Technopark Schlieren-Zürich
Wagistrasse 23
8952 Schlieren
13 Ergebnisse für "age" unter Bio-Technopark Schlieren-Zürich
Allergan and Molecular Partners Present Late-Breaking Data from Pha...
... Investigational Abicipar pegol in Neovascular Wet Age-Related Macular Degeneration DUBLIN, IRELAND – OCTOBER 11 ... SEQUOIA clinical studies of investigational Abicipar in patients with neovascular (wet) age-related ... -from-phase-3-studies-of-investigational-abicipar-pegol-in-neovascular-wet- age-related-macular ... Abicipar pegol in Neovascular Wet Age-Related Macular Degeneration › BIO-TECHNOPARK® Schlieren-Zürich Show ...
Molecular Partners Provides Regulatory Update of European and Japan...
... ) for abicipar pegol, a novel DARPin therapeutic for patients with neovascular (wet) age-related macular ... neovascular (wet) age-related macular degeneration (nAMD). Following the recent decision from the U.S. Food ...
